This compound is a boronic ester derivative used as a pharmaceutical intermediate in the manufacturing of acalabrutinib impurities. It features an amide linkage, aromatic rings, and a heterocyclic structure, contributing to its role in controlled laboratory synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-2-pyridinyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
research compound
1-Boc-4-Fmoc-2-piperazinecarboxylic acid
pharmaceutical intermediate
3-Cyano-4-fluorobenzaldehyde
pharmaceutical intermediate
(R)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical intermediate
L-Homoserine lactone hydrochloride
pharmaceutical intermediate
N-pyridin-2-yl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
LKLRQEMMBDWQJT-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)C(=O)NC3=CC=CC=N3
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.